BackRelmada Therapeutics Overview

Relmada Therapeutics Net Tangible Assets

Track Relmada Therapeutics's net tangible assets ($220M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$218.73M

Peer average

Loading

Relmada Therapeutics Net Tangible Assets History

Loading

Relmada Therapeutics vs. peers: Net Tangible Assets Comparison

Loading

Relmada Therapeutics Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Relmada Therapeutics (RLMD) FAQ

Relmada Therapeutics (RLMD) currently reports a net tangible assets of $220M as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Relmada Therapeutics's net tangible assets history and peer comparisons.

Relmada Therapeutics's net tangible assets changed from $0 to $220M (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Relmada Therapeutics reported $220M in net tangible assets as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $220M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Relmada Therapeutics, and consider following RLMD for alerts when major investors trade the stock.

Relmada Therapeutics is classified in the Consumer Discretionary sector. On net tangible assets, it currently shows $220M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Consumer Discretionary are usually more informative than comparing RLMD with unrelated industries.